An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...

Overall, women with more advanced MS disability had similar peripartum relapse activity as those with less disability, ...

So welcome to our Pharma Day 2025 here in London. It's good to see here full house. I was told we have, I think, a record attendance here on site, and we also have quite a high number, I think, of web ...

Healthy’ woman diagnosed with rare autoimmune disorder after rash - Tia Rey now struggles to walk or stand for long periods and is often breathless ...

After numerous blood tests and support from a rheumatology specialist, Ms Rey was diagnosed with antisynthetase syndrome, a rare autoimmune disorder causing painful muscle inflammation and arthritis.

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition.

An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...

Dr Jiwon Oh looks forward to hearing updates on major clinical trials and long-term studies of new and emerging MS treatments at ECTRIMS 2025.

The McDonald criteria revisions provide a unified approach for diagnosing MS from pediatric to late-life presentations, said ...

Better diagnostics and more treatment options have modestly improved interstitial lung disease management in patients with ...

The latest revisions to the McDonald criteria seek to provide a unified framework for the most accurate diagnosis of MS ...

For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...